Medifocus Inc. (TSXV-MFS)


The breast cancer treatment sector is split between chemical or biological agents, and devices aimed at killing or removing cancerous tumors. Medifocus enjoys a decided advantage, as demand for procedures resulting in cosmetically acceptable outcomes is growing. Medifocus' minimally invasive, non-toxic, focused microwave technology platform is able to target and treat tumors 1 – 8 cm in diameter, unlike radio frequency devices or laser-induced thermotherapy. Additionally, the system can be used to eradicate microscopic breast tumors that cannot be seen by surgeons.

The Medifocus, Inc. Prolieve System is an in-office technology, a medical device that both heats the prostate using focused microwaves and dilates the prostatic urethra. The purpose of the Prolieve System is to treat the symptoms of enlarged prostate (BPH) in men who would benefit from drug or surgical therapy. The treatment was designed with patients' needs and comfort in mind.


Medifocus, Inc. (TSXV-MFS)
© 2007 - 2023 Medifocus. All Rights Reserved. Legal Disclaimers